The Uncertainty of the Association Between Proton Pump Inhibitor Use and the Risk of Dementia: Prescription Sequence Symmetry Analysis Using a Korean Healthcare Database Between 2002 and 2013

Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies

(2017) Edward Chia-Cheng Lai et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study

(2017) Shelly L. Gray et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan

(2017) Shu-Yu Tai et al.   PLoS One

Risk factors for dementia diagnosis in German primary care practices

(2016) Anke Booker et al.   INTERNATIONAL PSYCHOGERIATRICS

Association of Proton Pump Inhibitors With Risk of Dementia

(2016) Willy Gomm et al.   JAMA Neurology

Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer’s disease

(2015) Alaina Baker-Nigh et al.   BRAIN

Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans

(2015) Hugh C. Hendrie et al.   ETHNICITY & DISEASE

Active-comparator design and new-user design in observational studies

(2015) Kazuki Yoshida et al.   Nature Reviews Rheumatology

Risk of dementia in elderly patients with the use of proton pump inhibitors

(2014) Britta Haenisch et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Statin use and incident dementia: A nationwide cohort study of Taiwan

(2014) Chian-Ying Chou et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B12Deficiency

(2013) Jameson R. Lam et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection

(2013) Izyan A. Wahab et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production

(2013) Nahuai Badiola et al.   PLoS One

Nonsteroidal anti-inflammatory drug use and the risk of cognitive impairment and Alzheimer’s disease

(2012) Sharlène Côté et al.   Alzheimers & Dementia

Statins in the prevention of dementia and Alzheimer's disease: A meta-analysis of observational studies and an assessment of confounding

(2012) William B. Wong et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

Histamine-2 Receptor Antagonist Use and Incident Dementia in an Older Cohort

(2011) Shelly L. Gray et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Midlife homocysteine and late-life dementia in women. A prospective population study

(2009) Dimitri E. Zylberstein et al.   NEUROBIOLOGY OF AGING

Changes in folate, vitamin B12 and homocysteine associated with incident dementia

(2008) J-M Kim et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY